To combine P2Y2The dry eye treatment agent that receptor stimulating agent and hyaluronic acid or its salt are characterized

The application is related to combine P2Y 2 The application of dry eye treatment agent, the treatment method of xerophthalmia and dry eye treatment agent that receptor stimulating agent and hyaluronic acid or its salt are characterized.The present invention provides a kind of dry eye treatment agent, it is characterised in that be the P2Y that will treat valid density 2 The hyaluronic acid or the combination of its salt of receptor stimulating agent and treatment valid density are obtained, formulation is ophthalmic agent, because the dry eye treatment agent is while lacrimal secretion is remarkably promoted, corneal epithelial diseases are also significantly improved, it is therefore contemplated that it turns into new dry eye treatment agent.